Global Payments Matches Q3 2026 Estimates as Revenue Rises 58% to $3.18B
Revenue of $3.18B vs. $3.18B expected and adjusted EPS of $3.58 vs. $3.58; revenue up 58% from a year earlier.
Global Payments (GPN) matched estimates for the third quarter of 2026. Revenue was $3.18 billion, up 58% from a year earlier, in line with the $3.18 billion estimate, and adjusted EPS was $3.58, up 9.8% from a year earlier, in line with the $3.58 estimate.
Q3 2026 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | $3.58 | $3.58 | In line |
| Revenue | $3.18B | $3.18B | In line |
| Change | YoY | QoQ |
|---|---|---|
| Adjusted EPS | ▲ 9.8% | ▲ 3.5% |
| Revenue | ▲ 58% | ▲ 0.7% |
By our calculation, the QoQ column compares with the previous quarter's revenue of $3.16 billion and adjusted EPS of $3.46. The YoY column compares with $2.01 billion and $3.26 in the same quarter a year earlier.
Track record
- EPS record. Adjusted EPS beat the estimate in 6 of the last 8 reports, including this one.
- Revenue record. Revenue beat the estimate in 4 of the last 8 reports.
- Revenue trend. Revenue over the last 5 reports, oldest first: $2.01 billion, $2.32 billion, $2.86 billion, $3.16 billion and $3.18 billion.
What to watch
- Next-quarter estimates. Consensus calls for EPS of $3.66 and revenue of $3.16 billion next quarter, based on 21 analysts.
- Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 58% increase to $3.18 billion.
- Estimate record. Whether Global Payments extends a record of beating EPS estimates in 6 of its last 8 reports.
- Related coverage. See our reports on ANI Pharmaceuticals, Molson Coors Beverage, Kontoor Brands and Dnow.
Sources: Results are from Global Payments's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Global Payments's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
ANI Pharmaceuticals Beats Q3 2026 Estimates as Revenue Rises 28% to $290.8M
EarningsMolson Coors Beverage Beats Q3 2026 Estimates as Revenue Rises 15% to $3.40B
EarningsKontoor Brands Q3 2026 EPS Tops Estimates at $1.50, but Revenue Misses at $685.3M
EarningsDnow Q3 2026 EPS Tops Estimates at $0.18, but Revenue Misses at $1.34B
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.
